Using royal jelly to reduce inflammation and oxidative stress in people with high blood pressure
Official title: Royal Jelly as a Strategy to Modulate Inflammation and Oxidative Stress in Patients With Systemic Arterial Hypertension
Run by Universidade Federal Fluminense · NCT06917131 · Data updated 2026-11-12
This study is testing if royal jelly can help reduce inflammation and oxidative stress in people with high blood pressure who are already taking medication.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 34 (estimated) |
| Sponsor | Universidade Federal Fluminense Academic / other |
| Locations | 1 site (Rio de Janeiro, Rio de Janeiro) |
| Status | Recruiting |
| Started | September 18, 2024 |
| Main results expected | December 10, 2026 |
| Study ends | December 10, 2026 |
| Registry record updated | May 19, 2026 |
| Trial ID | NCT06917131 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients with systemic arterial hypertension who are currently on one to three antihypertensive medications and have stable medication doses.
✕Probably not a fit
Patients with autoimmune diseases, diabetes, chronic kidney disease, liver disease, cancer, or those who are pregnant will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effects of royal jelly on inflammation and oxidative stress in individuals with systemic arterial hypertension. It is designed as a longitudinal double-blind randomized clinical trial lasting two months, involving participants who are already on antihypertensive medications. The research aims to explore the potential of royal jelly, known for its antioxidant and anti-inflammatory properties, as a natural supplement for managing hypertension. The study will compare the effects of royal jelly against a placebo to determine its efficacy in improving health outcomes.
Why it matters
Potential benefit: If successful, this study could provide a natural supplement option for managing hypertension and reducing related health risks.
How similar studies have gone: While there is promising data from in vitro and animal studies regarding royal jelly, clinical studies in human populations are still limited, making this approach relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of stage 1 hypertension * Regular treatment for more than 6 months * No changes in medication doses during the last 3 months Exclusion Criteria: * Autoimmune diseases * Infectious diseases * Diabetes * Chronic kidney disease * Liver disease * Cancer * AIDS * Pregnant women * Use of catabolic drugs or antibiotics * Use of antioxidant vitamin supplements, prebiotics, probiotics, or synbiotics * Habitual intake of royal jelly * Allergy to bee stings * Acute myocardial infarction (AMI) * Stroke (CVA)
Where it's running
-
Denise Mafra
Rio de Janeiro, Rio de Janeiro, Brazil Recruiting
Study contacts
- Principal investigator: Ludmila Cardozo, PhD — Universidade Federal Fluminense
- Study coordinator: Denise mafra, PhD
- Email: dmafra30@gmail.com
- Phone: +5521985683003
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Heart, kidney, and metabolic health in Shanghai community residents
This follow-up will track people from the STONE cohort to see if changes in metabolic risk factors over time relate to heart and kidney outcomes.
-
Using low-dose aspirin after preeclampsia to improve recovery
This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.
-
Tailored digital support to cut sedentary time in long-term cardiac rehab
In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.
-
IMB-guided health education to boost medication taking and blood pressure control in adults with hypertension
This study tests a health-literacy program based on Information-Motivation-Behavioral Skills to help adults with hypertension who don’t take their medicines regularly to take them more consistently and better control their blood pressure.
-
Renal Nerve Stimulation to Help Blood Pressure in AF and HFpEF
This study tests whether stimulating the kidneys with a catheter can safely lower blood pressure in adults with atrial fibrillation and HFpEF who also have hypertension.
-
Hypertension: Does Education Help Patients Manage Blood Pressure Better?
This study tests whether structured patient education improves blood pressure control and self-management in adults with hypertension who speak Turkish.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.